Table 2.
Baseline clinical characteristics of 99 HIV-positive MSM with or without GBV-C infection
| GBV-C viraemia status | GBV-C positive (n = 27) | GBV-C negative (n = 72) | P |
|---|---|---|---|
| Median age (years) | 25 (24–31) | 30 (24–39) | 0·064* |
| Median days of HIV infection | 30 (17–30) | 30 (28–46) | 0·11* |
| HIV subtype | |||
| CRF01-AE | 15/27 (55·6%) | 36/72 (50%) | 0·62† |
| B | 9/27 (33·3%) | 21/72 (29·2%) | 0·69† |
| B/C | 3/27 (11·1%) | 7/72 (9·7%) | 1† |
| C | 0 | 2/72 (1·4%) | 1† |
| Not detected | 0 | 6/72 (8·3%) | |
| HBsAg positive | 1/27 (3·7%) | 1/72 (1·39%) | 0·47† |
| Anti-HCV positive | 0 | 1/72 (1·39%) | 1† |
| Syphilis | 7/27 (25·9%) | 13/72 (18·1%) | 0·385† |
| Median (IQR 25–75%) (log10 copies/ml) | 4·29 (3·69–5·51) | 4·83 (3·97–5·58) | 0·31* |
| Median (IQR 25–75%) CD4 counts (cells/mm3) | 423 (361–587) | 506 (334–602) | 0·46* |
MSM, Men who have sex with men; IQR, interquartile range.
*
Mann–Whitney test.
†
Two-sided Pearson's χ2 test.